Broadfin Capital is a New-York-based company focused on investments in healthcare companies.
Business Model:
Revenue: $12M
Employees: 51-200
Address: 300 Park Ave 25th Floor
City: New York
State: NY
Zip: 10022
Country: US
Broadfin Capital is a venture capital firm that invests in the healthcare industry.
Contact Phone:
+12128082460
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2013 | Intra-Cellular Therapies | Secondary Market | 60M |
8/2022 | Heron Therapeutics | Post-IPO Equity | 76.5M |
12/2013 | RedHill Biopharma | Post-IPO Equity | 8.5M |
6/2015 | Aralez Pharmaceuticals | Post-IPO Equity | 0 |
4/2021 | Arch Oncology | Series C | 0 |
6/2015 | Ardelyx | Post-IPO Equity | 77.8M |
7/2015 | Recro Pharma | Post-IPO Equity | 16M |
1/2015 | Strongbridge Biopharma | Venture Round | 27.5M |
1/2020 | Sonendo | Venture Round | 85M |
4/2018 | Strata Skin Sciences | Post-IPO Equity | 17M |
5/2018 | BioDelivery Sciences | Post-IPO Equity | 50M |
6/2016 | Iovance Biotherapeutics | Equity | 100M |
2/2015 | Advaxis | Post-IPO Equity | 0 |
2/2015 | Tonix Pharmaceuticals | Post-IPO Equity | 28.7M |
4/2021 | Arch Oncology | Series C | 0 |
1/2020 | Sonendo | Venture Round | 0 |
5/2018 | BioDelivery Sciences | Post-IPO Equity | 0 |
4/2018 | Strata Skin Sciences | Post-IPO Equity | 0 |
6/2016 | Iovance Biotherapeutics | Post-IPO Equity | 0 |
7/2015 | Recro Pharma | Post-IPO Equity | 0 |
6/2015 | Ardelyx | Post-IPO Equity | 0 |
6/2015 | Aralez Pharmaceuticals | Post-IPO Equity | 0 |
2/2015 | Advaxis | Post-IPO Equity | 0 |
2/2015 | Tonix Pharmaceuticals | Post-IPO Equity | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|